Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
Ontology highlight
ABSTRACT: Though immune correlates for protection are still under investigation, potent cytotoxic T lymphocyte responses are desirable for an ideal HIV-1 vaccine. PD-1 blockade enhances SIV-specific CD8+ T cells. However, little information has been reported about how it affects the immunogenicity and protection of prophylactic SIV vaccines in nonhuman primates. Here, we show that PD-1 blockade during vaccination substantially improved protective efficacy in SIV challenged macaques. The PD-1 pathway was blocked using a monoclonal antibody specific to human PD-1. Administration of this antibody effectively augmented and sustained vaccine-induced SIV-specific T cell responses for more than 42 weeks after first immunization in rhesus monkeys, as compared with SIV vaccination only. Importantly, after in
SUBMITTER: Pan E
PROVIDER: S-EPMC6206945 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA